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Several years ago, I saw a cartoon by Glasbergen of a girl 
talking to a young boy. The caption read, "Let's play doctor. 
I'll give you a list of my ailments, and you blame it all on my 
hormones." To me, this cartoon epitomizes one side of the 
ongoing debate as to whether women patients are appropri- 
ately and fairly treated for their medical symptoms and signs 
of disease. In cardiology, this debate focuses on the question 
of whether women with symptoms of coronary artery disease 
receive the same intensity of diagnostic testing and treat- 
ment as do men. This question stimulates strong emotional 
responses in cardiologists and epidemiologists (1). 
Coronary Artery Survival Study registry study. The Coro- 
nary Artery Survival Study (CASS) registry study by Davis et 
al. (2) in this issue of the Journal appears to side with those 
who suggest hat such bias in the treatment of women with 
coronary artery disease does not occur. The CASS registry 
study analyzed rates of coronary artery bypass surgery and 
long-term survival in -15,000 men and women who had 
operable coronary artery disease at the time of their initial 
coronary angiography. Women in the study were, on average, 
3 years older and had higher ates of diabetes and symptomatic 
congestive heart failure and angina than study men. However, 
the men had more extensive coronary artery disease and 
poorer left ventricular contraction scores than the women. The 
rate at which coronary artery bypass urgery was performed in
the women compared with that in the men was not different, 
and there were few differences in the long-term survival of the 
men and women. These results appear to suggest that physi- 
cians offered surgical therapy to women patients with operable 
coronary artery disease on the basis of their symptoms, coro- 
nary anatomy and left ventricular function. The decision- 
making process was apparently not biased by the gender of the 
patient (2). 
These results are reassuring and suggest that once coro- 
nary angiography is performed, physicians use these objec- 
tive data to make rational decisions about revascularization. 
Moreover, the CASS registry study is consistent with other 
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studies uggesting that after angiography, the utilization of 
coronary revascularization procedures, including coronary 
artery bypass urgery, is not greater in men than in women 
(3-6). The CASS registry study appears to present proof 
that if there is a bias against women in aggressively diag- 
nosing and treating coronary artery disease, it occurs before 
coronary angiography. The sophisticated statistical nalysis, 
the large number of patients in the study, the nearly 
complete follow-up data, the strong study design and the 
impressive reputations of these scientists all strengthen the 
conclusions of the CASS registry study. 
However, I believe that the conclusions of Davis et al. (2) 
should be interpreted cautiously. There is strong evidence of 
bias in the way that we treat women with suspected coronary 
artery disease. This evidence is found in several disciplines of 
medicine and is supported by retrospective cohort studies, 
registries and case series from individual hospitals. Most 
critically, in addition to this evidence, the conclusions drawn 
from the CASS registry study are based on information 
gleaned from a highly selected group of women. Conclusions 
based on their management are probably not generalizable to 
most women with symptoms of coronary disease. 
Gender bias in clinical decisions. In the field of clinical 
decision analysis, there is evidence that clinical decisions are 
influenced by a patient's gender. In fact, the cultural milieu in 
which the patient and physician operate may be as important as 
the biomedical considerations ofwhether apatient is offered a 
diagnostic test or therapy. Characteristics of the patient, the 
clinician, the health care system and the relationship of the 
clinician to the patient are all important sociologic influences 
in the clinical decision process. A patient's gender may be one 
of these important sociologic variables. Physicians may diag- 
nose and treat women, at least in part, on the basis of gender 
biases learned uring their medical training and careers (7). 
In the field of epidemiology, there is also strong evidence 
that coronary artery disease is treated ifferently in men and 
women. Coronary artery disease incidence, prevalence and 
case fatality rates and initial presentation of symptomatic 
coronary artery disease certainly differ between men and 
women. However, these epidemiologic differences are not 
great. In the United States, coronary artery disease is the 
leading cause of death in women. The number of deaths each 
year from coronary artery disease is not different for men and 
women (8). Between the ages of 45 and 64 years, the preva- 
lence of coronary heart disease is approximately twice as high 
in men. After age 65, this difference ssentially disappears. 
Death rates from coronary artery disease tend to mirror the 
prevalence rates. For women and men between the ages of 45 
and 64 years, the death rate from coronary artery disease is 
about three times higher in men than women. However, the 
death rate after age 65 becomes essentially the same (9,10). 
Angina pectoris is common in women, and whether it is 
diagnosed by a physician or by use of a standardized question- 
naire, is prevalent in >5% of women between the ages of 40 
and 60 years. This is not greatly different from the rate found 
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in men, although women in most studies have a higher ate of 
angina than their male counterparts (1). Clearly, the gender 
differential of coronary artery disease between men and 
women is not as great as has been previously suggested (11). 
Despite this similarity between men and women in the 
burden of coronary artery disease, men are much more likely 
than women to undergo aggressive treatment for symptomatic 
coronary artery disease. For example, men are four to five 
times more likely than women to undergo coronary artery 
bypass urgery (3). This difference between men and women in 
utilization of coronary artery bypass urgery persists even after 
adjusting for principal diagnosis, age, heart failure, diabetes, 
race and insurance status. Even in the setting of an acute 
myocardial infarction, and with women reporting higher ates 
of disability from angina, women are only half as likely as men 
to undergo cardiac atheterization r bypass urgery. Clinical 
variables, including functional status, do not appear to greatly 
change this discrepancy (5). 
Utilization of diagnostic and therapeutic procedures for 
coronary artery disease in men and women at individual tertiary 
care referral hospitals is less consistent than at multiple-site 
studies. Some series show that women are older and are 
referred for bypass urgery later in the course of their disease 
than men, with women likely to be referred for unstable 
angina, postmyocardial infarction angina or heart failure. Men, 
in contrast, were referred because of abnormal exercise toler- 
ance tests (12). Other series show similar rates of utilization 
after acute myocardial infarction. In one large series (4), the 
rate of coronary artery angiography and angioplasty was not 
different in patients of similar ages, but women appeared less 
likely to undergo bypass surgery than men. In another large 
series (13), there was no difference in utilization of coronary 
artery bypass urgery, but the reasons why women were offered 
bypass surgery differed from those in men. Women in the 
lowest risk group, those least likely to benefit from operation, 
were offered bypass surgery less frequently than their male 
counterparts in the same risk group. In the highest risk group, 
the group most likely to benefit from operation, there was no 
difference in rates of bypass urgery (13). 
Women also appear to have a higher death rate after 
operation or acute myocardial infarction. For example, women 
are more likely to die during an acute myocardial infarction 
than men. In fact, male case fatality rates rarely surpass female 
rates after an acute coronary event (11). Early hospital mor- 
tality after coronary artery bypass surgery also appears to be 
higher for women than men (14-16). This excess mortality in 
women is probably due to multiple factors, such as the older 
age of the women, the higher ate of associated comorbidity or 
the increased acuity of women at the time of operation. 
However, many investigators (16) do not believe that these 
factors explain all the high risk of coronary artery bypass 
surgery. The smaller body size of women and the smaller 
coronary arteries, which may be less suitable for bypass 
grafting, are believed to explain some of this excess risk. This 
excess risk was reported early in the CASS study, as well as by 
other investigators (15). 
Finally, another line of evidence supporting differential 
treatment ofwomen compared with men is philosophical. The 
debate about utilization of procedures in coronary artery 
disease often uses the language of exploitation and attributes 
differences in outcomes between men and women back to 
women. Women are conceptualized as a cause of the problem. 
This ideologic process of unintentional nd well-meaning, yet 
often self-serving, distortion of reality is seen in many social 
and public health problems (17). In the context of coronary 
artery disease, this language often suggests that coronary 
artery disease is a "man's disease," that women may have 
symptoms out of proportion to the extent of their coronary 
artery obstructions and that when women's arteries are af- 
fected, their arteries are "bad for revascularization." The 
context of the debate is thus put in the context of a problem 
with women rather than in the context of the causes of the 
disease itself. 
Generalizability of CASS registry study. The CASS regis- 
try study addresses many of these key issues. In my opinion, it 
is a valid, internally consistent study that has limited general- 
izability. My concerns about he study are based on two lines of 
reasoning. First, the analysis is based on a highly selected 
group of women who are unlikely to be representative of most 
women with coronary artery disease. Second, it was not clear to 
me when the decision-making for coronary bypass surgery 
actually occurred. It may have occurred, at least in part, well 
before the cardiac catheterization was performed. Physicians 
may be less objective than suggested by the CASS registry 
study if they have already decided to offer an operation, 
provided that the test shows an operable coronary lesion. 
The CASS registry was designed to serve as a repository of 
information on patients undergoing coronary angiography for 
a clinical trial of medical and surgical treatment of coronary 
disease (18). By no means is this registry representative of the 
U.S. population with coronary artery disease. Referral for 
cardiac catheterization is a complex process that is almost 
certainly influenced by clinical and nonclinical factors. The 
CASS registry cannot be used to test a hypothesis about 
selection bias in cardiac catheterization. Furthermore, if a 
conditional decision to refer to bypass urgery precedes cardiac 
catheterization, an analysis of a registry is of limited value in 
assessing ender bias in coronary artery disease surgery rates. 
That such selection pressures occurred in the CASS registry 
study is suggested by the proportion of men and women within 
the registry. There was no age limit for entry into the registry 
(18), and one should not expect a great difference in the 
proportion of men and women in the registry. However, the 
difference in men and women in the registry is huge. After 
excluding men and women who had nonoperable coronary 
artery disease, only slightly <16% of the patients in the study 
were women. Even within the age range of most patients in the 
study, one would expect more women to have been entered 
into the registry. This ratio 5 or 6 to 1 of men to women should 
have been closer to the ratio of 2:1 of men to women expected 
within the 45- to 64-year old age group, as described previ- 
ously. This ratio is also greater than the 3:1 ratio of coronary 
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death rates of men and women within this age group. Almost 
certainly, strong selection pressures contributed to determin- 
ing which patients with symptomatic coronary artery disease 
were referred for coronary angiography. 
That -50% of the women in the registry have normal 
coronary arteries compared with only 20% of the men only 
suggests to me that there were different reasons for referring 
men and women for coronary angiography. These differential 
reasons were not homogeneous within each gender group. 
Some women may have been referred for advanced coronary 
artery disease; others may have been referred for severe, but 
nonspecific, chest pain. The reasons for referral to angiography 
for men may have been more homogeneous and may have 
reflected more specific symptoms. Women do not appear to 
have been offered cardiac atheterization for the same reasons 
as men. 
This type of selection process, which discriminates some 
types of patients with coronary disease from others, does not 
invalidate the main results of a clinical trial. In fact, it may be 
the only way in which the clinical trial can proceed. However, 
it does limit the generalizability of the findings to the types of 
patients who were in the study. Questions that are particularly 
vulnerable to limits of generalizability are generally those that 
are not related to the initial hypothesis of the trial, as in this 
example. In general, selection procedures are often adequate 
to protect he original hypothesis. 
Conclusions. The CASS registry study presents a sophisti- 
cated analysis of a group of women who had operable coronary 
artery disease defined by cardiac atheterization. At best, this 
study can only draw conclusions about women who reach this 
advanced stage of their diagnostic evaluation. No conclusion 
can be drawn about the selection process by which women are 
referred for angiography. Even for women at this stage of their 
diagnostic evaluation, it seems that the conclusions are not 
generalizable. In the important debate of whether women are 
discriminated against in the diagnosis and management of
coronary artery disease, the CASS registry study provides ome 
encouraging information. In a highly selected group of women, 
bias does not occur. However, these findings should not be 
extended to most women with coronary artery disease. 
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